Literature DB >> 12620402

PTEN and p53: who will get the upper hand?

Lloyd C Trotman1, Pier Paolo Pandolfi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12620402     DOI： 10.1016/s1535-6108(03)00022-9

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  42 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

2.  Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiation.

Authors:  Baltazar D Aguda; Yangjin Kim; Hong Sug Kim; Avner Friedman; Howard A Fine
Journal:  Biophys J       Date:  2011-11-01       Impact factor: 4.033

Review 3.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

4.  Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.

Authors:  Miodrag Dragoj; Jasna Bankovic; Evangelia Sereti; Sofija Jovanovic Stojanov; Konstantinos Dimas; Milica Pesic; Tijana Stankovic
Journal:  Invest New Drugs       Date:  2017-07-22       Impact factor: 3.850

5.  Involvement of miR-605 and miR-34a in the DNA damage response promotes apoptosis induction.

Authors:  Chun-Hong Zhou; Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  Biophys J       Date:  2014-04-15       Impact factor: 4.033

6.  Ubiquitination regulates PTEN nuclear import and tumor suppression.

Authors:  Lloyd C Trotman; Xinjiang Wang; Andrea Alimonti; Zhenbang Chen; Julie Teruya-Feldstein; Haijuan Yang; Nikola P Pavletich; Brett S Carver; Carlos Cordon-Cardo; Hediye Erdjument-Bromage; Paul Tempst; Sung-Gil Chi; Hyo-Jong Kim; Tom Misteli; Xuejun Jiang; Pier Paolo Pandolfi
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

Review 7.  Beyond chemotherapy: targeted therapies in ovarian cancer.

Authors:  Timothy A Yap; Craig P Carden; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Authors:  Zhenbang Chen; Lloyd C Trotman; David Shaffer; Hui-Kuan Lin; Zohar A Dotan; Masaru Niki; Jason A Koutcher; Howard I Scher; Thomas Ludwig; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

9.  Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis.

Authors:  John M Perry; Linheng Li
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

10.  Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.

Authors:  Suzana S Couto; Mei Cao; Paulo C Duarte; Whitney Banach-Petrosky; Shunyou Wang; Peter Romanienko; Hong Wu; Robert D Cardiff; Cory Abate-Shen; Gerald R Cunha
Journal:  Differentiation       Date:  2008-10-16       Impact factor: 3.880
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.